Samsung Biologics expands Korea CRDMO lead with MCB and vector services Samsung Biologics widens CRDMO edge with new MCB and ...

REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveraging OpenCRISPR-1™, an AI-designed genome editing system ...

In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...

Could an answer to Spencer’s spotty cell phone service be on the horizon? Planning and Zoning Administrator Steve Blount ...

Samsung Biologics has unveiled new contract development organization services as the Korean biopharmaceutical giant a ...

The U.S. Department of Health and Human Services (HHS) announced on Thursday that it will stop funding research that uses ...

Welcome to my first contribution to Solar Power World, part of a new series of articles looking specifically at U.S. solar ...

HUICHENG DISTRICT, HUIZHOU CITY, GUANGDONG PROVINCE, CHINA, January 16, 2026 /EINPresswire.com/ -- The global market ...

PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech” or the "Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...

Advances in inflammasome biology are helping researchers address key selectivity and safety challenges in drug development.

US FDA grants Orphan Drug Designation to BlueRock Therapeutics’ investigational cell therapy OpCT-001 to treat retinitis pigmentosa: Berlin, Germany Friday, January 23, 2026, 09 ...